Cerebral Metabolic Changes in Diabetes Type 2 Studied Using in-vivo Proton MRS

Keywords

abnormalities absence according acid acts adolescents amino among assay authors axial blood brain brand care carried cascade cause cell cells central cerebral chronic clinic clinically coil committee complete concentration control controls criteria damage decreased dementia density depicting diabetes diabetic diagnosed disease disturbance disturbances documented done dysfunction earlier encephalopathy ethics examinations except exclude facility findings flow fluid frontal function functional glucose health healthy history hyperglycemia hypoglycemia hypoglycemic in vivo indicated indicative informed institute integrity interactions involved laboratory lead lipid literature localized loss maintenance major marker matrix medical medicine metabolic metabolites namely neoplasm nervous neuronal obese occipital oral osmotic particularly patient patients pharmacology physical press primary problem progressive proton public pulse putative recent recruited reduced reflects regular related reports review role sciences sclerosis select seven significantly slice slowly sonata spectra spectroscopy spectrum stimulate stroke student studied studies subject subjects subtle suggested supporting table target temporal though thought type vascular viability volume volunteers white whole worldwide